Cargando…

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity

Procoagulant platelets are associated with an increased risk for thrombosis. Procoagulant platelet formation is mediated via Cyclophilin D (CypD) mediated opening of the mitochondrial permeability transition pore. Inhibiting CypD activity could therefore be an interesting approach to limiting thromb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Bael, Jens, Vandenbulcke, Aline, Ahmed-Belkacem, Abdelhakim, Guichou, Jean-François, Pawlotsky, Jean-Michel, Samyn, Jelle, Barendrecht, Arjan D., Maas, Coen, De Meyer, Simon F., Vanhoorelbeke, Karen, Tersteeg, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139176/ https://www.ncbi.nlm.nih.gov/pubmed/37108326 http://dx.doi.org/10.3390/ijms24087163

Ejemplares similares

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2016)

The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection
por: Kheyar, Amel, et al.
Publicado: (2023)

Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication
por: Lahaye, Xavier, et al.
Publicado: (2016)

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity
por: Nevers, Quentin, et al.
Publicado: (2018)

Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2014)

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)
por: Softic, Laurent, et al.
Publicado: (2020)

Artificial MiRNA Knockdown of Platelet Glycoprotein lbα: A Tool for Platelet Gene Silencing
por: Thijs, Tim, et al.
Publicado: (2015)

Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation
por: Vermeersch, Elien, et al.
Publicado: (2018)

Cyclophilin A Isomerisation of Septin 2 Mediates Abscission during Cytokinesis
por: Gorry, Rebecca L., et al.
Publicado: (2023)

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo
por: Reddy, Emily C., et al.
Publicado: (2020)

Procoagulant platelets: Generation, characteristics, and therapeutic target
por: Chu, Yaxin, et al.
Publicado: (2021)

Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura
por: Deforche, Louis, et al.
Publicado: (2016)

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
por: Aliotta, Alessandro, et al.
Publicado: (2020)

Cytosolic and mitochondrial Ca(2+) signaling in procoagulant platelets
por: Millington-Burgess, Sarah L., et al.
Publicado: (2021)

Another piece of knowledge in the puzzle of procoagulant COAT platelets
por: Aliotta, Alessandro, et al.
Publicado: (2022)

Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers
por: Agbani, Ejaife O., et al.
Publicado: (2023)

Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets
por: Tegegn, Tseday Z., et al.
Publicado: (2016)

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
por: Smith, Christopher W., et al.
Publicado: (2022)

Targeted SERPIN (TaSER): A dual‐action antithrombotic agent that targets platelets for SERPIN delivery
por: Sanrattana, Wariya, et al.
Publicado: (2021)

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Roose, Elien, et al.
Publicado: (2018)

The role of platelet and endothelial GARP in thrombosis and hemostasis
por: Vermeersch, Elien, et al.
Publicado: (2017)

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients
por: Tullemans, Bibian M. E., et al.
Publicado: (2018)

Analysis of procoagulant phosphatidylserine‐exposing platelets by imaging flow cytometry
por: Reddy, Emily C., et al.
Publicado: (2018)

Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets
por: Beke Debreceni, Ildikó, et al.
Publicado: (2019)

Antibody-induced procoagulant platelets in severe COVID-19 infection
por: Althaus, Karina, et al.
Publicado: (2021)

Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets
por: Aliotta, Alessandro, et al.
Publicado: (2021)

Increased procoagulant platelet levels are predictive of death in COVID-19
por: Khattab, Mohamad H., et al.
Publicado: (2021)

Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis
por: Ma, Ruishuang, et al.
Publicado: (2017)

Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity
por: Harper, M T, et al.
Publicado: (2013)

Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis
por: Agbani, Ejaife O., et al.
Publicado: (2018)

Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
por: Haghbeen, Marzieh, et al.
Publicado: (2021)

Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent
por: Pelzl, Lisann, et al.
Publicado: (2022)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Publisher Correction: Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis
por: Ma, Ruishuang, et al.
Publicado: (2018)

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood
por: de Vries, Joost C., et al.
Publicado: (2019)

Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity
por: Hernández, M Rosa, et al.
Publicado: (2012)

Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients
por: Zhao, Liangliang, et al.
Publicado: (2016)

Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
por: Ji, Shuting, et al.
Publicado: (2019)

Extracellular mitochondria released from traumatized brains induced platelet procoagulant activity
por: Zhao, Zilong, et al.
Publicado: (2020)

Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO)
por: Marcinkowska, Adrianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kseeq21qncsc5a845cigp9k7c